218 related articles for article (PubMed ID: 15489383)
1. Effects of botulinum toxin type A on vibration induced facilitation of motor evoked potentials in spasmodic torticollis.
Urban PP; Rolke R
J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1541-6. PubMed ID: 15489383
[TBL] [Abstract][Full Text] [Related]
2. The utility of EMG interference pattern analysis in botulinum toxin treatment of torticollis: a randomised, controlled and blinded study.
Werdelin L; Dalager T; Fuglsang-Frederiksen A; Regeur L; Karlsborg M; Korbo L; Munck O; Winge K
Clin Neurophysiol; 2011 Nov; 122(11):2305-9. PubMed ID: 21636319
[TBL] [Abstract][Full Text] [Related]
3. Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals.
Sloop RR; Cole D; Patel MC
Mov Disord; 2001 Jan; 16(1):100-5. PubMed ID: 11215566
[TBL] [Abstract][Full Text] [Related]
4. [The central action of botulinum toxin type A assessed by brain auditory and somatosensory evoked potentials].
Sławek J; Recławowicz D
Neurol Neurochir Pol; 2004; 38(2):93-9. PubMed ID: 15307601
[TBL] [Abstract][Full Text] [Related]
5. Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A.
Houser MK; Sheean GL; Lees AJ
J Neurol Neurosurg Psychiatry; 1998 May; 64(5):577-80. PubMed ID: 9598669
[TBL] [Abstract][Full Text] [Related]
6. [Spasmodic torticollis: experience of 5 years with botulinum toxin treatment].
Domzał TM
Neurol Neurochir Pol; 1999; 33(2):351-7. PubMed ID: 10463249
[TBL] [Abstract][Full Text] [Related]
7. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
[TBL] [Abstract][Full Text] [Related]
8. The effective zone of botulinum toxin A injections in the sternocleidomastoid muscle.
Lee JH; Lee BN; Han SH; An XC; Chung RH
Surg Radiol Anat; 2011 Apr; 33(3):185-90. PubMed ID: 20886338
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia.
Naumann M; Yakovleff A; Durif F;
J Neurol; 2002 Jan; 249(1):57-63. PubMed ID: 11954869
[TBL] [Abstract][Full Text] [Related]
10. Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment.
Nijmeijer SWR; de Bruijn E; Verhagen R; Forbes PA; Kamphuis DJ; Happee R; Tijssen MAJ; Koelman JHTM
Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28832550
[TBL] [Abstract][Full Text] [Related]
11. Selective peripheral denervation for spasmodic torticollis: 13-year experience with 155 patients.
Braun V; Richter HP
J Neurosurg; 2002 Sep; 97(2 Suppl):207-12. PubMed ID: 12296680
[TBL] [Abstract][Full Text] [Related]
12. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
[TBL] [Abstract][Full Text] [Related]
13. Bilateral Lower Sternocleidomastoid Botulinum Toxin Injections to Address Refractory Anterocollis.
Peng-Chen Z; Thompson A; Rodriguez RL
Neurologist; 2016 Mar; 21(2):30-1. PubMed ID: 26926853
[TBL] [Abstract][Full Text] [Related]
14. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
[TBL] [Abstract][Full Text] [Related]
15. Quantitative electromyography-guided botulinum toxin treatment of cervical dystonia.
Finsterer J; Fuchs I; Mamoli B
Clin Neuropharmacol; 1997 Feb; 20(1):42-8. PubMed ID: 9037572
[TBL] [Abstract][Full Text] [Related]
16. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia.
Ansved T; Odergren T; Borg K
Neurology; 1997 May; 48(5):1440-2. PubMed ID: 9153487
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of botulinum toxin type A against cervical dystonia and muscular hypertonia in persons with severe motor and intellectual disabilities with respiratory problems and/or dysphagia].
Yokoyama M; Honda M; Okoshi Y; Masuyama T; Iwasaki Y; Arima M
No To Hattatsu; 2011 Jul; 43(4):273-6. PubMed ID: 21800689
[TBL] [Abstract][Full Text] [Related]
19. Somatosensory cortical activation in cervical dystonia and its modulation with botulinum toxin: an fMRI study.
Opavský R; Hluštík P; Otruba P; Kaňovský P
Int J Neurosci; 2012 Jan; 122(1):45-52. PubMed ID: 21919815
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A relieves sternocleidomastoid muscle fibrosis in congenital muscular torticollis.
Jiang B; Zu W; Xu J; Xiong Z; Zhang Y; Gao S; Ge S; Zhang L
Int J Biol Macromol; 2018 Jun; 112():1014-1020. PubMed ID: 29447964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
